Infective Endocarditis in Developing Countries, a Prospective, Observational, Multicentre Study
NCT ID: NCT02128139
Last Updated: 2025-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2012-04-30
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives: Description of the characteristics (clinical and microbiological) and assessment of the outcomes of infective endocarditis in low-income countries.
Methods : Prospective, Observational, Multicentre study. Inclusion criteria: patients aged over 1 year fulfilling the modified Duke criteria for infective endocarditis.
Exclusion criteria: patient included during a previous infective endocarditis episode.
Outcomes measures: Mortality at 6 months follow-up; mortality at 1 month follow-up; access to antibiotic treatment (modalities and duration), hospital length of stay and reason for discharge, and cardiac surgery when indicated.
Duration: One year (June 2014- June 2015)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predisposition to Infectious Endocarditis
NCT03979261
Evolution of the Profile of Infectious Endocarditis in France in 2008 (EI2008)
NCT03295045
Infective Endocarditis in the Elderly
NCT02910856
Inflammatory Profiles of Children at High Risk for Atherosclerosis
NCT00115232
A Survey of Hospitalizations in Cardiology Units in Sub-Saharan Africa
NCT03231449
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Year
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
War Memorial Hospital
OTHER
Centers for Disease Control and Prevention
FED
Oxford University Hospitals NHS Trust
OTHER
St. Elizabeth Catholic General Hospital Shisong, Cameroun
UNKNOWN
CHU de Brazzaville, Congo Brazzaville
UNKNOWN
Polyclinique International de Bamako, Mali
UNKNOWN
CHR de Saint-Louis Lt Colonel Mamadou Diouf, Sénégal
UNKNOWN
Hôpital Général de Grand Yoff de Dakar, Sénégal
UNKNOWN
Bafoussam Regional Hospital, Cameroon
UNKNOWN
Hospital Laquinitinie de Douala
UNKNOWN
Yaounde Central Hospital
OTHER_GOV
National Hospital of Niamey
OTHER
Centre National Hospitalier Universitaire de Pneumo-Phtisiologie de Cotonou, Benin
UNKNOWN
Hospital General De Douala
OTHER
Eduardo Mondlane University
OTHER
Laos Oxford Mahosot Wellcome Research Unit
UNKNOWN
Mulago Hospital, Uganda
OTHER
Fann Hospital, Senegal
UNKNOWN
Institute of Cardiology Abidjan
UNKNOWN
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Joseph Kado
Suva, , Fiji
Paul N. Newton
Vientiane, , Laos
Beatriz Ferreira
Maputo, , Mozambique
Abdul Kane
Dakar, , Senegal
Bara Diop
Dakar, , Senegal
Emmy Okello
Kampala, , Uganda
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Cardiology and Development
Identifier Type: OTHER
Identifier Source: secondary_id
C12-37 / EndoDev
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.